FDA set to approve CRISPR gene editing to cure disease affecting 20M Black and Brown people worldwide

PLUS: OpenAI looks to hire a new CEO ... again. This time it's looking to hire a rival's CEO and merge the two companies.

Today’s Top Stories at the Intersection of Tech, Race, and Gender

👩🏽‍🔬🥼 Hope for Healing Sickle Cell Anemia: U.S. Federal Drug Administration (FDA) considers cutting edge treatment for disease that primarily affects Black people, sickle cell anemia. CRISPR gene editing for sickle cell anemia would be the first FDA approval for such a treatment option.